Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 10;44(1):53.
doi: 10.1007/s10792-024-03049-1.

The application of high-throughput sequencing technology in corneal diseases

Affiliations
Review

The application of high-throughput sequencing technology in corneal diseases

Jing Yi Zhao et al. Int Ophthalmol. .

Abstract

High-throughput sequencing technology, also known as next-generation sequencing technology, can explore new biomarkers and specific gene mutations. It has a pivotal role in promoting the gene research, which can limit the detection area, lessen the time needed for sequencing. Also, it can quickly screen out the suspected pathogenic genes of patients, gain the necessary genetic data, and provide the basis for clinical diagnosis and genetic counseling. In the research of corneal diseases, through the DNA sequencing of patients' diseased cells, it can provide a deeper understanding of corneal diseases and improve the diagnosis, classification and treatment alternatives of various corneal diseases. This article will introduce the application progress of high-throughput sequencing technology in corneal diseases, which will help to understand the application of this technology in various corneal diseases.

Keywords: Adjuvant therapy; Corneal diseases; Disease diagnosis; High-throughput sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests in this section.

Figures

Fig. 1
Fig. 1
The process of high-throughput sequencing technology (by Figdraw)

Similar articles

References

    1. Di Iorio E, Barbaro V, Alvisi G, et al. New frontiers of corneal gene therapy. Hum Gene Ther. 2019;30(8):923–925. doi: 10.1089/hum.2019.026. - DOI - PubMed
    1. Brunette I, Roberts CJ, Vidal F, et al. Alternatives to eye bank native tissue for corneal stromal replacement. Prog Retin Eye Res. 2017;59:97–130. doi: 10.1016/j.preteyeres.2017.04.002. - DOI - PubMed
    1. Morganti S, Tarantino P, Ferraro E, et al. Complexity of genome sequencing and reporting: next generation sequencing (NGS) technologies and implementation of precision medicine in real life. Crit Rev Oncol Hematol. 2019;133:171–182. doi: 10.1016/j.critrevonc.2018.11.008. - DOI - PubMed
    1. Sabour L, Sabour M, Ghorbian S. Clinical applications of next-generation sequencing in cancer diagnosis. Pathol Oncol Res. 2017;23(2):225–234. doi: 10.1007/s12253-016-0124-z. - DOI - PubMed
    1. Hu T, Chitnis N, Monos D, et al. Next-generation sequencing technologies: an overview. Hum Immunol. 2021;82(11):801–811. doi: 10.1016/j.humimm.2021.02.012. - DOI - PubMed

LinkOut - more resources